SCHEMBL19655271

SCHEMBL19655271

c1ccc(-c2ccc(-n3c4ccccc4c4cc5c(cc43)c3ccccc3n5-c3nc4ccccc4nc3-c3ccccc3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.42
L3MBTL1 Q9Y468 4/20 0.42
ATM Q13315 1/20 0.42
HSD17B10 Q99714 2/20 0.40
CASP1 P29466 1/20 0.40
HRH4 Q9H3N8 1/20 0.40
DHODH Q02127 2/20 0.39
ALDH1A1 P00352 4/20 0.39
GAA P10253 2/20 0.39
HPGD P15428 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
LMNA P02545 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
HSP90AA1 P07900 1/20 0.38
MAPT P10636 1/20 0.38
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
HDAC4 P56524 1/20 0.37
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19655274 0.97 KDM4E (0.46) KDM4EL3MBTL1ATMHSD17B10CASP1
SCHEMBL19507837 0.95 KDM4E (0.49) KDM4EL3MBTL1ATMHSD17B10CASP1
SCHEMBL20348048 0.94 KDM4E (0.41) KDM4EL3MBTL1ATMHSD17B10CASP1
SCHEMBL18926357 0.94 KDM4E (0.45) KDM4EL3MBTL1ATMHSD17B10CASP1
SCHEMBL21709120 0.94 KDM4E (0.41) KDM4EL3MBTL1ATMHSD17B10CASP1
SCHEMBL20348103 0.93 KDM4E (0.39) KDM4EL3MBTL1ATMHSD17B10CASP1
SCHEMBL19655302 0.93 KDM4E (0.44) KDM4EL3MBTL1ATMHSD17B10CASP1
SCHEMBL24596647 0.92 HSD17B10 (0.40) KDM4EL3MBTL1ATMHSD17B10CASP1
SCHEMBL19655137 0.92 HSD17B10 (0.46) KDM4EL3MBTL1ATMHSD17B10CASP1
SCHEMBL19655305 0.92 HPGD (0.38) KDM4EL3MBTL1ATMHSD17B10CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840458-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-11-17 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES PDXK, MT-ND4L, PNPO KDM4E 2543/4885L3MBTL1 2020/4885ATM 3559/4885
US-10840458-B2 Organic electroluminescent materials and devices PDXK, MT-ND4L, PNPO KDM4E 2543/4885L3MBTL1 2020/4885ATM 3559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.